Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
Simple Summary
- Supplementary File 1:
PDF-Document (PDF, 206 KiB)
Poprach, A.; Holanek, M.; Chloupkova, R.; Lakomy, R.; Stanik, M.; Fiala, O.; Melichar, B.; Kopeckova, K.; Zemanova, M.; Kiss, I.; Penka, I.; Bohosova, J.; Buchler, T. Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry. Cancers 2020, 12, 2911. https://doi.org/10.3390/cancers12102911
Poprach A, Holanek M, Chloupkova R, Lakomy R, Stanik M, Fiala O, Melichar B, Kopeckova K, Zemanova M, Kiss I, Penka I, Bohosova J, Buchler T. Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry. Cancers. 2020; 12(10):2911. https://doi.org/10.3390/cancers12102911
Chicago/Turabian StylePoprach, Alexandr, Milos Holanek, Renata Chloupkova, Radek Lakomy, Michal Stanik, Ondrej Fiala, Bohuslav Melichar, Katerina Kopeckova, Milada Zemanova, Igor Kiss, Igor Penka, Julia Bohosova, and Tomas Buchler. 2020. "Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry" Cancers 12, no. 10: 2911. https://doi.org/10.3390/cancers12102911